Validation & Studies

Data integrity is critical when relied upon for remote monitoring, risk stratification, and decision-making. Through partnering with universities and other research organizations, Biostrap’s biometric measurements have been validated against gold standard diagnostic equipment in 14 publications and 22 clinical studies.
bg blur
Coronavirus disease 2019 - Coronavirus
4 bWVkaWMtMDIuanBn scaled
Chemical substance - Liquid
neurons and nervous system 2021 08 26 15 33 01 utc scaled

Recent Publications

IG CovidSameer

A 35-year-old CEO who detected COVID-19 with his wearable biosensor - a Case Report

The COVID-19 pandemic has led more people to start using wearable technology to track vital signs, physical activity, and sleep. The significant features of these devices include their capability to collect continuous, noninvasive data. We developed a COVID-19 risk stratification model using the Biostrap wearable device which utilizes a baseline-adjusted continuous scale and other escalation points-based on our recent case report, to enhance the National Early Warning Score (NEWS2). Preliminary research has found that our adjusted Early Warning Score (Biostrap-EWS) might be highly specific in identifying early-stage respiratory infections. We present the case of Biostrap CEO Sameer Sontakey, a 35-year-old man, whom the app notified as having a high likelihood of respiratory illness after which the diagnosis SARS-CoV-2 was confirmed with a nasal swab. Our Biostrap-EWS algorithm appears to detect respiratory infections in a real-world environment via passively collected biometric data.

Depositphotos 336415838 XL scaled

Two cases of COVID-19 monitored by a wearable biosensor- a case report

With the Biostrap wrist-worn device (Biostrap USA LLC, Duarte, CA, USA), a commercially available, clinically validated wearable device that uses photoplethysmography to automatically record physiological data such as resting heart rate, respiratory rate, oxygen saturation (SpO2), and arterial stiffness (AS), we collected biometric data from 933 subjects. We present two cases of patients who have tested positive for the presence of severe acute respiratory syndrome (SARS-CoV-2), a 24-year-old man experiencing major symptoms and another a 49-year-old man with only intermittent fatigue, and show the marked changes in biometric measurements around dates of symptom onset and positive test. We observed a pattern of sustained respiratory rate elevation in both patients, punctuated by a sharp spike in heart rate and decreased AS. The latter contradicted our expectation that during the onset of symptoms of COVID-19, an increase in AS might occur.

All Publications

IG CovidSameer

A 35-year-old CEO who detected COVID-19 with his wearable biosensor - a Case Report

Depositphotos 336415838 XL scaled

Two cases of COVID-19 monitored by a wearable biosensor- a case report

IMG NotAvailable02

Usability of a Wrist-Worn Smartwatch in a Direct-to-Participant Randomized Pragmatic Clinical Trial

IMG NotAvailable02

Assessment of Pulse Wave Pressure Changes for Detection of Arrhythmia and Comorbidities Using a Wrist-Worn Wearable Device

IMG NotAvailable02

An Overview of the Feasibility of Permanent, Real-Time, Unobtrusive Stress Measurement with Current Wearables

IMG NotAvailable02

Preliminary Evaluation of a Wrist Wearable Heart Rate Sensor for the Detection of Undiagnosed Atrial Fibrillation in a Real-World Setting

IMG NotAvailable02

Machine Learning Detection of Obstructive Hypertrophic Cardiomyopathy Using a Wearable Biosensor

IMG NotAvailable02

Changes in Physiologic Signals During Sleep due to Arrhythmia

publications 3 1

Cardiorespiratory Physiology Remotely Monitored via Wearable Wristband Photoplethysmography: Feasibility and Initial Benchmarkin

IMG NotAvailable02

Estimation of HRV and SpO2 from Wrist-Worn Commercial Sensors for Clinical Settings

IMG NotAvailable02

Design Rationale and Performance Evaluation of the Wavelet Health Wristband: Benchtop Validation of a Wrist-Worn Physiological Monitor